New grant: Ox4TB Philip Fowler, 17th March 202517th March 2025 Very pleased to announce that I am a co-investigator on the recently announced Oxford4TB project that has been funded by the Ineos Oxford Institute for antimicrobial research (IOI). The project will received £5 million over three years and the main aim is to develop new therapies for multi-drug resistant tuberculosis. We will be guiding the selection of targets and leads using our large dataset of >50k clinical tuberculosis samples. Each sample has phenotypic drug susceptibility testing and whole genome data so we will be able to e.g. check there are no mutations in circulation that could lead to resistance of any new compound. I will be advertising a post to work on this project in a few months time. Share this:TwitterBlueskyEmailLinkedInMastodon Related antimicrobial resistance clinical microbiology tuberculosis
New publication: fast human read decontamination for SARS-CoV-2 16th May 202216th May 2022 ReadItAndKeep is a new human-read decontamination algorithm that works by mapping the reads in a… Share this:TwitterBlueskyEmailLinkedInMastodon Read More
New preprint: validating antibiotic resistance prediction in our Myco pipeline 9th November 202413th January 2025 Over the last 18 months or so we’ve been designing, coding and testing a Mycobacterial… Share this:TwitterBlueskyEmailLinkedInMastodon Read More
antimicrobial resistance New preprint: looking at rifampicin-resistant subpopulations in clinical samples 10th April 202510th April 2025 Since clinical samples are usually grown in a MGIT tube for a while before some… Share this:TwitterBlueskyEmailLinkedInMastodon Read More